CEO Naito Selected among The Best-Performing CEOs in the World by Harvard Business Review
Harvard Business Review has just announced The Best-Performing CEOs in the World, in which CEO Haruo Naito was ranked 87th. Among Japanese companies, only three other CEOs made the list, including Nidec’s Shigenobu Nagamori (42nd), FAST RETAILING’s Tadashi Yanai (46th) and Softbank’s Masayoshi Son (73rd).
From the pharmaceutical industry, only Novo Nordisk’s Lars Rebien Sørensen (1st), Biogen’s George Scangos (21st) and Regeneron Pharmaceuticals’ Leonard Schliefer (67th) made the list, making CEO Naito the only one selected from the Japanese pharmaceutical industry.
Please refer to the following link for further details on the announcement.
This CEO ranking was based on companies in the S&P Global 1200, from 895 CEO’s of 886 companies in 32 countries. The final ranking is calculated based on a financial element measured by shareholder returns and change in market capitalization since becoming CEO of the company as well as a non-financial element assessing ESG (environment, social and governance) initiatives.